Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.0%
    Check dated 2025-09-09T00:58:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as additional drug information and publications related to acute myeloid leukemia. Some previous location details and drug information have been removed.
    Difference
    8%
    Check dated 2025-09-01T20:53:49.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-25T17:33:00.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.5%
    Check dated 2025-08-18T13:51:16.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-11T09:33:04.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-04T07:35:38.000Z thumbnail image

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.